Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | +2.46% | +7.81% | +17.61% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.61% | 99.55M | |
+18.50% | 47.02B | |
+48.77% | 41.86B | |
+1.15% | 41.76B | |
-4.27% | 28.8B | |
+11.40% | 26.05B | |
-21.28% | 19.15B | |
+4.69% | 12.55B | |
+27.75% | 12.34B | |
-3.65% | 11.82B |
- Stock Market
- Equities
- CRVS Stock
- News Corvus Pharmaceuticals, Inc.
- Corvus Pharmaceuticals to Start Phase 1 Study of Atopic Dermatitis Treatment in Q2